The demand for heart attack diagnostic devices has increased due to the rising need for continuous monitoring of individuals and accessibility for a patient. Incidence of diabetes and hypertension increases globally due to unhealthy lifestyles are likely to drive the growth of the heart attack diagnosis market. For instance, according to the Centers for Disease Control and Prevention, about 735,000 Americans suffer from a heart attack every year.
Besides, the increasing geriatric population and increasing obesity among the population, contribute to the noteworthy growth for the market. For instance, according to the World Health Organization (WHO), in 2019, more than 38.0 million children were overweight. Obesity and overweight are also on the rise in low- and middle-income regions. For instance, in African countries, the number of overweight populations increased by 24% since 2000. As a result, obesity will stimulate the incidences of cardiovascular problems. ultimately drive the growth of the heart attack diagnosis market.
However, higher investments in R&D and technological advancement in the healthcare sector will provide lucrative growth opportunities to the market in the coming years.
Heart Attack Diagnostics Market Segment Overview
ECG has a larger application and contributes to the incredible growth of the market. ECG is one of the most commonly used medical tests for the diagnosis of heart attacks. ECG monitoring systems, event monitors, implantable loop recorders, cardiac telemetry, and ECG data management solutions are the modern techniques contributing to the growth of the ECG market. However, the low Medicare reimbursements provided for the peripatetic cardiac outpatient telemetry electrocardiogram (ECG) is expected to hinder the growth of this segment in the forecast period. The troponin blood test segment has remarkable market growth. This is due to the rapid, accurate results within a short period.
Heart Attack Diagnostics Regional Overview
North America is anticipated to dominate the market in the global heart attack diagnostics market during the forecast period. Increasing diabetic and obesity population is the key aspect positively affecting growth of the heart attack diagnostic market in the region. Furthermore, the market of the Asia Pacific is projected to grow at the fastest rate owing to rising death rates because of heart diseases in the region.
Heart Attack Diagnostics Market Competitor overview
Recently, in June 2020, Novo Nordisk NOVOb.CO has agreed to buy AstraZeneca spin-off Corvidia Therapeutics for an initial $725 million as the world's largest diabetes drugmaker seeks to expand into cardiovascular disease treatments.
Heart Attack Diagnostics Market, Key Players
· Abbott Laboratories
· Beckman Coulter
· Bio-Rad Laboratories Inc.
· Siemens Healthcare Diagnostics
· GE Healthcare
· Life Sign LLC
· Hitachi Medical Systems
· Schiller AG.
· Midmark Corporation
· Koninklijke Philips N.V.
· Bionet Co., Ltd.
· Welch Allyn
· Toshiba Medical Systems Corporation
· Mortara Instrument
· F. Hoffmann-La Roche Ltd.
Heart Attack Diagnostics Market Segmentation
Heart Attack Diagnostics Market, By Test
· Electrocardiogram (ECG)
· Blood Test
· Chest X-Ray
· Echocardiogram
· Coronary Catheterization (Angiogram)
· Exercise Stress Test
· Magnetic Resonance Imaging (MRI)
Heart Attack Diagnostics Market, By End-user
· Hospitals
· Specialty Clinics
· Pathology
Heart Attack Diagnostics market, By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Test
- 5.2.1. Electrocardiogram (ECG)
- 5.2.2. Blood Test
- 5.2.3. Chest X-Ray
- 5.2.4. Echocardiogram
- 5.2.5. Coronary Catheterization (Angiogram)
- 5.2.6. Exercise Stress Test
- 5.2.7. Magnetic Resonance Imaging (MRI)
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Hospitals
- 5.3.2. Specialty Clinics
- 5.3.3. Pathology
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Latin America
- 5.4.3. Europe
- 5.4.4. Asia Pacific
- 5.4.5. Middle East and Africa
6. North America Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Test
- 6.2.1. Electrocardiogram (ECG)
- 6.2.2. Blood Test
- 6.2.3. Chest X-Ray
- 6.2.4. Echocardiogram
- 6.2.5. Coronary Catheterization (Angiogram)
- 6.2.6. Exercise Stress Test
- 6.2.7. Magnetic Resonance Imaging (MRI)
- 6.3. Market Analysis, Insights and Forecast – By End-user
- 6.3.1. Hospitals
- 6.3.2. Specialty Clinics
- 6.3.3. Pathology
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Latin America Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Test
- 7.2.1. Electrocardiogram (ECG)
- 7.2.2. Blood Test
- 7.2.3. Chest X-Ray
- 7.2.4. Echocardiogram
- 7.2.5. Coronary Catheterization (Angiogram)
- 7.2.6. Exercise Stress Test
- 7.2.7. Magnetic Resonance Imaging (MRI)
- 7.3. Market Analysis, Insights and Forecast – By End-user
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Pathology
- 7.4. Insights and Forecast – By Country
- 7.4.1. Brazil
- 7.4.2. Mexico
- 7.4.3. Rest of Latin America
8. Europe Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Test
- 8.2.1. Electrocardiogram (ECG)
- 8.2.2. Blood Test
- 8.2.3. Chest X-Ray
- 8.2.4. Echocardiogram
- 8.2.5. Coronary Catheterization (Angiogram)
- 8.2.6. Exercise Stress Test
- 8.2.7. Magnetic Resonance Imaging (MRI)
- 8.3. Market Analysis, Insights and Forecast – By End-user
- 8.3.1. Hospitals
- 8.3.2. Specialty Clinics
- 8.3.3. Pathology
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. UK
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Italy
- 8.4.5. Spain
- 8.4.6. Russia
- 8.4.7. Rest of Europe
9. Asia Pacific Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Test
- 9.2.1. Electrocardiogram (ECG)
- 9.2.2. Blood Test
- 9.2.3. Chest X-Ray
- 9.2.4. Echocardiogram
- 9.2.5. Coronary Catheterization (Angiogram)
- 9.2.6. Exercise Stress Test
- 9.2.7. Magnetic Resonance Imaging (MRI)
- 9.3. Market Analysis, Insights and Forecast – By End-user
- 9.3.1. Hospitals
- 9.3.2. Specialty Clinics
- 9.3.3. Pathology
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. China
- 9.4.2. India
- 9.4.3. Japan
- 9.4.4. Australia
- 9.4.5. South East Asia
- 9.4.6. Rest of Asia Pacific
10. Middle East & Africa Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Test
- 10.2.1. Electrocardiogram (ECG)
- 10.2.2. Blood Test
- 10.2.3. Chest X-Ray
- 10.2.4. Echocardiogram
- 10.2.5. Coronary Catheterization (Angiogram)
- 10.2.6. Exercise Stress Test
- 10.2.7. Magnetic Resonance Imaging (MRI)
- 10.3. Market Analysis, Insights and Forecast – By End-user
- 10.3.1. Hospitals
- 10.3.2. Specialty Clinics
- 10.3.3. Pathology
- 10.4. Market Analysis, Insights and Forecast – By Country
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. Abbott Laboratories
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Beckman Coulter
- 11.6. Bio-Rad Laboratories Inc.
- 11.7. Siemens Healthcare Diagnostics
- 11.8. GE Healthcare
- 11.9. Life Sign LLC
- 11.10. Hitachi Medical Systems
- 11.11. Schiller AG.
- 11.12. Midmark Corporation
- 11.13. Koninklijke Philips N.V.
- 11.14. Bionet Co., Ltd.
- 11.15. Welch Allyn
- 11.16. Toshiba Medical Systems Corporation
- 11.17. Mortara Instrument
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
